Compare EVO & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | MFA |
|---|---|---|
| Founded | 1993 | 1997 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 1.0B |
| IPO Year | N/A | N/A |
| Metric | EVO | MFA |
|---|---|---|
| Price | $2.74 | $9.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $11.05 |
| AVG Volume (30 Days) | 96.7K | ★ 1.5M |
| Earning Date | 04-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | $10.02 |
| P/E Ratio | ★ N/A | $7.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $8.78 |
| 52 Week High | $4.80 | $10.57 |
| Indicator | EVO | MFA |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 42.10 |
| Support Level | $2.32 | $9.38 |
| Resistance Level | $3.78 | $9.79 |
| Average True Range (ATR) | 0.10 | 0.21 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 16.17 | 14.87 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.